<DOC>
	<DOCNO>NCT01910038</DOCNO>
	<brief_summary>The usual percentage patient receive 0.1 mg/Kg/d less prednisone 6 month treatment approximately 40 % . We believe add tocilizumab corticotherapy protocol could increase percentage 40 70 % . From immunological point view , believe see fall Th17 response ( corticoids alone ) , also rise Treg lymphocyte .</brief_summary>
	<brief_title>Evaluation Tocilizumab add-on Therapy Corticoids Horton 's Disease : Proof Concept Study .</brief_title>
	<detailed_description />
	<mesh_term>Giant Cell Arteritis</mesh_term>
	<mesh_term>Polymyalgia Rheumatica</mesh_term>
	<criteria>Age &gt; 50 an Diagnosis Horton 's disease define accord ACR criterion ( annex 1 ) . Newlydiagnosed disease corticotherapy start less 14 day ( exceptionally , + 7 additional day case delay obtain result BAT ) Biopsy temporal artery ( TAB ) compatible diagnosis HD : nonnecrotising giantcell arteritis granulomatous inflammatory infiltrate , usually locate intimamedia junction , make lymphocyte , macrophage multinucleated giant cell ; least evidence chronic inflammatory infiltrate make lymphocyte neutrophil eosinophil without giant cell . For men woman childbearing age , effective method contraception must use patient partner throughout treatment tocilizumab ( placebo ) 3 month end treatment . Breastfeeding authorise 3 month end treatment tocilizumab . Women consider risk pregnancy define menopause least one year surgically steriles ( ligature fallopian tube , bilateral ovariectomy hysterectomy ) Persons provide write informed consent Persons cover National Health Insurance Agency Pregnancy Dementia syndrome Nonobservant patient Patient live 150 km investigate centre Negative temporal artery biopsy History alcohol abuse drug abuse lead hospitalisation previous year Patient follow and/or treat another know autoimmune inflammatory disease Hypersensitivity tocilizumab one excipients Persons protection court guardianship Treatments : Patients already treat ( stopped treatment le 6 month earlier ) , Horton Disease another disease , Treatment anti TNFα , methotrexate , ciclosporin , cyclophosphamide , dapsone bolus corticoid . Patients longterm corticoid another disease Start treatment Horton 's disease one dose &gt; 1 mg/Kg whatever duration Infections : Chronic ( acute ) viral hepatitis B C Infection HIV Persistent severe infection require hospitalisation IV antibiotherapy 30 day precede inclusion Infection require oral antibiotic 14 day precede inclusion History active tuberculosis , histoplasmosis listeriosis Signs latent tuberculosis ( base history untreated contact , opacity 1 cm diameter lung Xray , positive vitro test ( Quantiferon Gold TSpotTB ) History sigmoiditis complicate diverticulosis , history peritonitis Unstable disease : uncontrolled diabetes history recurrent infection , unstable ischemic heart disease , Heart failure ≥ stage III/IV New York Heart Association , recent cerebrovascular accident , severe disease may , participation study opinion investigator , lead risk patient . Patients vascular risk Patients high cardiovascular risk : proven history coronary artery disease vascular disease , type 2 diabetes high cardiovascular risk * , vascular risk &gt; 20 % 10 year ( Framingham equation ) Severe dyslipidemia control lipidlowering treatment Active liver disease hepatocellular insufficiency Neutropenia ( &lt; 500/mm3 ) thrombopenia ( &lt; 50 000/mm3 ) Demyelinating disease central nervous system ( current past ) Neoplasia le 5 year , except skin cancer ( melanoma ) complete R0 resection</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2013</verification_date>
</DOC>